| 000 | 01841 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517160735.0 | ||
| 264 | 0 | _c20170925 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0179350 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAkershoek, Johanneke J | |
| 245 | 0 | 0 |
_aDifferential effects of Losartan and Atorvastatin in partial and full thickness burn wounds. _h[electronic resource] |
| 260 |
_bPloS one _c2017 |
||
| 300 |
_ae0179350 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aActins _xmetabolism |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAtorvastatin _xadministration & dosage |
| 650 | 0 | 4 |
_aBurns _xdrug therapy |
| 650 | 0 | 4 |
_aCicatrix _xpathology |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aLosartan _xadministration & dosage |
| 650 | 0 | 4 |
_aMuscle, Smooth _xchemistry |
| 650 | 0 | 4 |
_aNeutrophils _xmetabolism |
| 650 | 0 | 4 |
_aPeroxidase _xmetabolism |
| 650 | 0 | 4 |
_aSkin Transplantation _xmethods |
| 650 | 0 | 4 | _aSwine |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aWound Healing _xdrug effects |
| 700 | 1 | _aBrouwer, Katrien M | |
| 700 | 1 | _aVlig, Marcel | |
| 700 | 1 | _aBoekema, Bouke K H L | |
| 700 | 1 | _aBeelen, Rob H J | |
| 700 | 1 | _aMiddelkoop, Esther | |
| 700 | 1 | _aUlrich, Magda M W | |
| 773 | 0 |
_tPloS one _gvol. 12 _gno. 6 _gp. e0179350 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0179350 _zAvailable from publisher's website |
| 999 |
_c27277332 _d27277332 |
||